ARVO 2019 Annual Meeting is April 28 - May 2
Register for ARVO 2019 in Vancouver, BC
IOVS Special issue
View a special issue featuring the latest research on Dry EyeGlobal mentorship
Global mentors and mentees talk relationship buildingTraveling to ARVO 2019
Helpful tips for your trip to VancouverAdvocacy toolkits
Tools to influence vision research funding and policyARVO members among 2018 Champalimaud Vision Award winners
Seven scientists were recognized for their extraordinary scientific advances which led to the successful treatment of a genetic cause of childhood blindness, a version of Leber Congenital Amaurosis, and demonstrated the potential for future developments in gene therapy to cure other inherited diseases.
Publications grant
Apply for ARVO’s Publications Grant, available to authors who need funding assistance to publish in one of our three journals
ARVONews Fall 2018
View the newly redesigned ARVONews. Read about eye and vision researchers making their mark in research and business settings, interesting facts about ARVO journals, advocacy resources, a new online education platform, the latest from the ARVO Foundation and much more.
Upcoming Events
Imaging in the Eye Conference
Join your colleagues for the 2019 ARVO Imaging in the Eye Conference, April 26-27, 2019, in Vancouver, BC. Learn about the newest techniques and technologies in imaging.
ARVO key dates and deadlines
View a monthly listing of key dates and deadlines for the Eye and Vision Science Community
Plan your stay at ARVO 2019
Book your hotel room now and get the best selection for ARVO 2019 in Vancouver, Canada, April 28 - May 2
Latest news
Visit our Press Room to see the latest eye and vision research news and view ARVO press releases.
Telling the story of OCT
Optical coherence tomography (OCT) is a technology invented by ARVO members that helps preserve patients' sight, saves taxpayers billions of dollars and enables further discoveries in science and medicine. See how ARVO has shared the impact of OCT with vision scientists, patients, and policymakers.
